Closing the Assay Loop: Inside Anthropic's $400M Wet Lab Pivot
DDDr. Dereck Mush, MD, MBA
Sep 23
Coefficient Bio
AI drug discovery company acquired by Anthropic and integrated into its life sciences team.
What they do
Founded by Aris Theologis, Nathan C. Frey, Samuel Stanton and Joyce Hong, Coefficient Bio brought generative biology and scientific AI expertise to Anthropic through a reported April 2026 stock acquisition worth about $400 million.
The record
- Vertical
- Pharma & Drug Discovery
- Sub-segment
- Generative biology
- Product type
- Platform software
- Stage
- Growth
- Headquarters
- New York, NY, USA
- Region
- North America
- Founded
- 2025
- Total funding
- Undisclosed
Notable investors: Dimension.
Also in Pharma & Drug Discovery
Related on The Signal
The HealthTech Signal
Chai Discovery triples its valuation as pharma buys into AI-designed molecules
Chai Discovery triples its valuation as pharma buys into AI-designed molecules
DDDr. Dereck Mush, MD, MBA
Jul 16
AI is moving upstream, from molecule design into disease target identification itself
DDDr. Dereck Mush, MD, MBA
Mar 18
Is AI Drug Discovery Actually Working? What the 2026 Clinical Trial Data Shows
DDDr. Dereck Mush, MD, MBA
Jun 5